Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Theodore Schroeder Insider Profile
4 Followers
Theodore Schroeder, Director at Hyperion Therapeutics, holds 11.99K shares in Nabriva Therapeutics (Ticker: NBRVF), holds 11.01K shares in Collegium Pharmaceutical (Ticker: COLL), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX).
Theodore Schroeder Hyperion Therapeutics (HPTX)Director
Hyperion Therapeutics (HPTX)
Director
Ranked #92,841 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-77.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Theodore Schroeder holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 28, 2019 - Aug 28, 2020
Return:-70.40%
The most profitable trade made by Theodore Schroeder
Theodore Schroeder's Trading History
Hyperion Therapeutics
May 08, 2015
―
Uninformative Sell
170.20K
―
Collegium Pharmaceutical
May 22, 2020
Director
Uninformative Buy
―
$406.49K
Nabriva Therapeutics
Jan 31, 2023
Director
Uninformative Sell
646.50
$1.56K
Otonomy
―
―
―
$0.00
Cidara Therapeutics
―
Director
―
$0.00
Cadence Pharma
Mar 21, 2014
―
Uninformative Sell
4.48M
―
Trius Therap
―
―
―
―
List of latest transactions for each holding click on a transaction to see Theodore Schroeder's performance on stock
You May Also Like
Theodore Schroeder insider profile FAQ
What is the percentage of profitable transactions made by Theodore Schroeder?
The percentage of profitable transactions made by Theodore Schroeder is 0%.
What is the average return per transaction made by Theodore Schroeder?
The average return per transaction made by Theodore Schroeder is -77.30%.
What stocks does Theodore Schroeder hold?
Theodore Schroeder holds: HPTX, COLL, NBRVF, OTIC, CDTX, CADX, TSRX stocks.
What was Theodore Schroeder’s latest transaction?
Theodore Schroeder latest transaction was an Uninformative Sell of $646.50.
What was Theodore Schroeder's most profitable transaction?
Theodore Schroeder’s most profitable transaction was an Informative Buy of NBRVF stock on August 28, 2019. The return on the trade was -70.40%.
What is Theodore Schroeder's role in Hyperion Therapeutics?
Theodore Schroeder's role in Hyperion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.